Jeff Yass’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Jeff Yass’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-470	Closed	-$21K	–	14211
2021 Q4	$21K	Sell	470 -5,141	-92%	-$308K	﹤0.01%	12820
2021 Q3	$399K	Buy	+5,611	New	+$638K	﹤0.01%	9949
2020 Q4	–	Sell	-408	Closed	-$31K	–	11872
2020 Q3	$31K	Buy	+408	New	+$27.4K	﹤0.01%	10324
2020 Q2	–	Sell	-569	Closed	-$23K	–	11136
2020 Q1	$23K	Buy	569 +289	+103%	+$21.9K	﹤0.01%	9909
2019 Q4	$23K	Buy	+280	New	+$20K	﹤0.01%	9478

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Jeff Yass's ASLN Position: Q1 2022 in Review

Jeff Yass sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2022, closing a stake of 470 shares — an estimated $21K sold.

Jeff Yass first reported a position in ASLN in Q4 2019 and held it in 5 quarters. The position peaked at $399K in Q3 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q1 2022.

Jeff Yass reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Jeff Yass sold 470 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2022, an estimated $21K.
Jeff Yass first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 5 quarters.
Jeff Yass's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $399K in Q3 2021.
31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.